Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 220S220 trades$52.89M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
MGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Kuo David C*** See Remarks |  AAOIAPPLIED OPTOELECTRONICS, INC.Tax withholding | F | $78K 518 sh | Apr 24, 2026 |
| 8 | Murry Stefan J.Chief Financial Officer | AAOIAPPLIED OPTOELECTRONICS, INC. Tax withholding | F | $127K 846 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 8 | Murry Stefan J.Chief Financial Officer | AAOIAPPLIED OPTOELECTRONICS, INC. Tax withholding | F | $112K 746 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 8 | Kuo David C*** See Remarks | AAOIAPPLIED OPTOELECTRONICS, INC. Tax withholding | F | $85K 567 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 8 | Murry Stefan J.Chief Financial Officer | AAOIAPPLIED OPTOELECTRONICS, INC. Tax withholding | F | $164K 1,086 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 8 | Kuo David C*** See Remarks | AAOIAPPLIED OPTOELECTRONICS, INC. Tax withholding | F | $67K 447 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 6 | Gibson ChristopherDirector |  RXRXRECURSION PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $144K 40.0K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 5 | Boersma TravisDirector, Executive Chairman of Board, 10% Owner |  BROSDutch Bros Inc.Other acquisition or disposition | J | — 427 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 5 | Kunkel Julie T.Director |  BLMNBloomin' Brands, Inc.Grant or award | A | — 23.5K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 5 | DM Individual Aggregator, LLC10% Owner | BROSDutch Bros Inc. Other acquisition or disposition | J | — 17.2K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 5 | DM Trust Aggregator, LLC10% Owner | BROSDutch Bros Inc. Other acquisition or disposition | J | — 27.3K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 5 | Boersma TravisDirector, Executive Chairman of Board, 10% Owner | BROSDutch Bros Inc. Other acquisition or disposition | J | — 670 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 5 | Kunkel Julie T.Director | BLMNBloomin' Brands, Inc. Option exercise | M | — 19.7K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 5 | Boersma TravisDirector, Executive Chairman of Board, 10% Owner | BROSDutch Bros Inc. Other acquisition or disposition | J | — 13.3K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 5 | Abrahamsen Danielle NicoleChief Accounting Officer |  CVLTCOMMVAULT SYSTEMS INCGrant or award | A | — 1,258 sh | Apr 24, 2026 traded Apr 22, 2026 |
| 5 | DM Individual Aggregator, LLC10% Owner | BROSDutch Bros Inc. Other acquisition or disposition | J | — 13.3K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 5 | Boersma TravisDirector, Executive Chairman of Board, 10% Owner | BROSDutch Bros Inc. Other acquisition or disposition | J | — 19.3K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 5 | Boersma TravisDirector, Executive Chairman of Board, 10% Owner | BROSDutch Bros Inc. Other acquisition or disposition | J | — 17.2K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 5 | Boersma TravisDirector, Executive Chairman of Board, 10% Owner | BROSDutch Bros Inc. Other acquisition or disposition | J | — 27.3K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 5 | DM Trust Aggregator, LLC10% Owner | BROSDutch Bros Inc. Other acquisition or disposition | J | — 19.3K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 4 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $267K 19.1K sh | Apr 24, 2026 traded Apr 24, 2026 |
| 4 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $262K 19.1K sh | Apr 24, 2026 traded Apr 23, 2026 |
| 3 | O'Hara John CharlesDirector, Chief Financial Officer |  LAESSEALSQ CorpOpen-market sale · 10b5-1 plan | SELL | $31K 10.0K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 3 | O'Hara John CharlesDirector, Chief Financial Officer | LAESSEALSQ Corp Open-market sale · 10b5-1 plan | SELL | $29K 10.0K sh | Apr 24, 2026 traded Apr 23, 2026 |
| 3 | O'Hara John CharlesDirector, Chief Financial Officer | LAESSEALSQ Corp Open-market sale · 10b5-1 plan | SELL | $15K 5,250 sh | Apr 24, 2026 traded Apr 24, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 15.4K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 61.5K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 14.7K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 14.7K sh | Apr 24, 2026 traded Apr 24, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $125K 14.7K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 0 | Gibson ChristopherDirector | RXRXRECURSION PHARMACEUTICALS, INC. Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $125K 14.7K sh | Apr 24, 2026 traded Apr 24, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 61.5K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 14.7K sh | Apr 24, 2026 traded Apr 23, 2026 |
| 0 | Gibson ChristopherDirector | RXRXRECURSION PHARMACEUTICALS, INC. Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 15.4K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $125K 14.7K sh | Apr 24, 2026 traded Apr 23, 2026 |
| 44 | Hoag Erik DChief Financial Officer |  TNLTravel & Leisure Co.Open-market purchase | BUY | $66K 1,000 sh | Apr 23, 2026 traded Apr 23, 2026 |
| 44 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1.43M 12.1K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 43 | Sharma SanjaySee Remarks* |  SEICSEI INVESTMENTS COOpen-market sale | SELL | $2.11M 23.4K sh | Apr 23, 2026 traded Apr 23, 2026 |